8-KItem 5.02 · Officer/Director ChangeItem 9.01 · Financial Statements
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Charles River ($CRL) filed an 8‑K (Item 9.01) disclosing an Employment Offer Letter with Glenn Coleman…

Filed with the SEC on · Summarized by InvestorsBot

Charles River ($CRL) filed an 8‑K (Item 9.01) disclosing an Employment Offer Letter with Glenn Coleman dated Feb 12, 2026 (Exhibit 10.1). 8‑K signed Feb 18, 2026 by Matthew L. Daniel. 📄 #SECfilings #CorporateGovernance

Filing includes Exhibit 10.1 (offer letter) and Exhibit 104 (interactive XBRL). No other substantive disclosures in this 8‑K — review Exhibit 10.1 for employment terms. 🧾 $CRL #InsiderHiring #SECfilings

8‑K signed by Matthew L. Daniel (Corporate SVP, General Counsel, Corporate Secretary & Chief Compliance Officer) on Feb 18, 2026. Investors should consult the filed Exhibit 10.1 for specifics. 🔍 $CRL #CorporateGovernance #SECfilings

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Feb 25, 2026: $CRL agreed to sell its CDMO and Cell Solutions businesses to GI Partners for primarily…

8-K · February 25, 2026

Charles River ($CRL) filed an 8-K (Item 9.01) on Feb 18, 2026 — Exhibits: 99.1 press release (dated Feb…

8-K · February 18, 2026

Charles River ($CRL) 8‑K (Feb 18, 2026): issued press release with Q4 and FY results for period ended Dec…

8-K · February 18, 2026

Charles River names Glenn Coleman Corporate Executive VP & CFO, tentative start April 6, 2026.

8-K · February 18, 2026

Charles River ($CRL): Q4 DSA net book-to-bill ~1.1x as demand improved through H2 2025, led by small/mid…

8-K · January 13, 2026

Charles River ($CRL) presenting at J.P.

8-K · January 13, 2026